Diabetes

Filter

mazdutide

Mazdutide Outperforms Dulaglutide in Type 2 Diabetes Trial

January 2026

Mazdutide, a dual glucagon and GLP-1 agonist, delivers greater HbA1c and weight reductions than dulaglutide in people with type 2 diabetes.

Switch to Tirzepatide May Give Superior Glycaemic and Weight Benefits

Switching to tirzepatide yields greater HbA1c and weight reductions than escalating dulaglutide in Type 2 diabetes.

Beyond Glucose: Triglyceride Levels May Worsen Outcomes in Gestational Diabetes

Elevated triglycerides in well-controlled gestational diabetes linked to increased pregnancy risks, suggesting lipid monitoring may be crucial.

Mind-body Exercise Shows Powerful Effects in Type 2 Diabetes Management

Mind-body exercises show promising benefits for type 2 diabetes, improving blood sugar, weight, and heart health markers.

Higher eGDR May Signal Lower Mortality in Diabetes

Higher eGDR linked with lower mortality and cardiovascular risk in diabetes, offering promise for clinical risk stratification.

Diabetes Medications Show Promise in Dementia Prevention

Newer diabetes drugs linked to reduced risk of dementia in older adults, real-world data shows promising results.

Greater Metformin Use May Increase Risk of Diabetic Neuropathy

Study links metformin use to increased diabetic neuropathy risk in dose-dependent fashion.

Children Exposed to Gestational Diabetes Show Higher ADHD Risk

Understand how gestational diabetes is linked to ADHD symptoms in children.

Could Immunotherapy Change How We Treat Childhood Type 1 Diabetes?

Immunotherapy shows promise for improving glycaemic control in children with Type 1 diabetes.

Loading posts...

« Previous 1 … 9 10 11 12 13 … 41 Next »